Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 - December 2022

• Hoofdauteurs: Hinta Meijerink (Auteur), Lamprini Veneti (Auteur), Anja Bråthen Kristoffersen (Auteur), Anders Skyrud Danielsen (Auteur), Melanie Stecher (Auteur), Jostein Starrfelt (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2024-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Due to changes in testing policy and increased use of rapid tests, other indicators for SARS-CoV-2 infections are needed to monitor vaccine effectiveness (VE). We aimed to estimate VE against COVID-19 sick leave (> 3 days, certified by a medical professional) among employed in...